Literature DB >> 2822950

Efficient transformation by Prague A Rous sarcoma virus plasmid DNA requires the presence of cis-acting regions within the gag gene.

C M Stoltzfus1, L J Chang, T P Cripe, L P Turek.   

Abstract

A region in addition to and outside the long terminal repeats (LTRs) in the gag gene of the Prague A strain of Rous sarcoma virus was found to be essential in cis for efficient cell transformation by cloned viral DNA. Transformation in chicken embryo fibroblasts, which requires infectious virus production and reinfection, was facilitated in cis by sequences between nucleotides 630 and 1659. Efficient transformation of NIH 3T3 cells in which secondary spread of virus is not necessary (as it is in chicken embryo fibroblasts) required sequences between nucleotides 630 and 1149. A src cDNA clone which also lacks this region demonstrated low transformation efficiency, indicating that the role of the cis element cannot be attributed to interference with RNA splicing. The gag gene segment required in cis for transformation, between nucleotides 630 and 1149, could substitute for the simian virus 40 enhancer in either orientation, and cells transfected with Rous sarcoma virus LTR-driven plasmids containing the gag cis element had a two- to threefold increase in steady-state viral RNA levels compared with plasmids lacking this region. Thus, additional cis-acting regulatory elements located outside the viral LTRs may modulate viral gene expression and contribute to the efficiency of cell transformation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822950      PMCID: PMC255935          DOI: 10.1128/JVI.61.11.3401-3409.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Infectivity of proviral DNA from avian sarcoma virus-transformed mammalian cells.

Authors:  F Catala; P Vigier
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

2.  Structure of B77 sarcoma virus RNA: stabilization of RNA after packaging.

Authors:  C M Stoltzfus; P N Snyder
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Mechanism of transfection of chicken embryo fibroblasts by Rous sarcoma virus DNA.

Authors:  G M Cooper; S Okenquist
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

5.  Virogenic nontransformed cells isolated following infection of normal rat kidney cells with B77 strain Rous sarcoma virus.

Authors:  D Boettiger
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

6.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.

Authors:  M Linial; E Medeiros; W S Hayward
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells.

Authors:  G M Cooper; H M Temin
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

8.  Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.

Authors:  R C Strohman; P S Moss; J Micou-Eastwood; D Spector; A Przybyla; B Paterson
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

9.  Role of methylation in the induced and spontaneous expression of the avian endogenous virus ev-1: DNA structure and gene products.

Authors:  K F Conklin; J M Coffin; H L Robinson; M Groudine; R Eisenman
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

10.  Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.

Authors:  T H Haugen; T P Cripe; G D Ginder; M Karin; L P Turek
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  16 in total

1.  Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.

Authors:  J T Miller; C M Stoltzfus
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector.

Authors:  S Fuerstenberg; H Beug; M Introna; K Khazaie; A Muñoz; S Ness; K Nordström; J Sap; I Stanley; M Zenke
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells.

Authors:  C R Erdie; J W Wills
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  A transformation-competent recombinant between v-src and Rous-associated virus RAV-1.

Authors:  J Svoboda; J C Kandala; J Geryk; J Pichrtová; R V Guntaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Purification and properties of the Rous sarcoma virus internal enhancer binding factor.

Authors:  L Karnitz; D Poon; P A Weil; R Chalkley
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.

Authors:  J Bodor; J Svoboda
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Localization and footprinting of an enhancer within the avian sarcoma virus gag gene.

Authors:  K Carlberg; T A Ryden; K Beemon
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Tumor immunity generated in the course of regression of v-src-induced sarcomas.

Authors:  T W Wisner; J M England; D Y Pan; A W Stoker; M S Halpern
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.